A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Islam, Saidul
Άλλοι συγγραφείς:	Sharmin, Shahana
Μορφή:	Thesis
Γλώσσα:	English
Έκδοση:	Brac University 2022
Θέματα:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Διαθέσιμο Online:	http://hdl.handle.net/10361/17308

Παρόμοια τεκμήρια

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
ανά: Karim, Azrin
Έκδοση: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
ανά: Flora, Sanzida Alam
Έκδοση: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
ανά: Meem, Manila
Έκδοση: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
ανά: Alam, Tahera
Έκδοση: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
ανά: Jahan, Nusrat
Έκδοση: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
ανά: Ahmed, Nafisa
Έκδοση: (2023)

Immunotherapy in the Management of Lung Cancer
ανά: Tasnim, Humayra
Έκδοση: (2022)

A review on triple-negative breast cancer and its potential treatment
ανά: Niasa, Jannatul Ferdous
Έκδοση: (2023)

Stem cells as therapeutic carrier in cancer treatment
ανά: Anika, Mysha Yeasmin
Έκδοση: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
ανά: Hasan, Amit
Έκδοση: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
ανά: Chakraborty, Anuradha
Έκδοση: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
ανά: Khan, Muidul Hasan
Έκδοση: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
ανά: Roy, Hredita
Έκδοση: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
ανά: Emon, Kamrul Hasan
Έκδοση: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
ανά: Mirza, Maisa Tasnim
Έκδοση: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
ανά: Khan, Rezia Nowrin
Έκδοση: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
ανά: Nuha, Nabiha Tahsin
Έκδοση: (2024)

Role of statins as antagonists of SPARC in gastric cancer
ανά: Shahmat, Rad
Έκδοση: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
ανά: Sorno, Rubina Haque
Έκδοση: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
ανά: Ratu, Tabassum
Έκδοση: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
ανά: Choki, Kinley
Έκδοση: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
ανά: Razna, Amrin Islam
Έκδοση: (2019)

A comprehensive review on drug repurposing in cancer treatment
ανά: Sarkar, Onusree
Έκδοση: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
ανά: Mahaleka, Aarshi
Έκδοση: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
ανά: Shaikat, Mahdi Mubin
Έκδοση: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
ανά: Hasan, Sakib
Έκδοση: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
ανά: Nawar, Anika
Έκδοση: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
ανά: Deeba, Maliha Tasnim
Έκδοση: (2018)

Targeting BRAFV600E in the treatment of CRC
ανά: Roja, Mashwiyat Samrin
Έκδοση: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
ανά: Alam, Kazi Tasnuva
Έκδοση: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
ανά: Rahman, Sanjida
Έκδοση: (2024)

Biosimilar in lymphoma treatment
ανά: Tanisha, Mehrin Haque
Έκδοση: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
ανά: Khondokar, Faiza
Έκδοση: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
ανά: Islam, Nahidul
Έκδοση: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
ανά: Beruni, Sajid Mahmud Al
Έκδοση: (2022)

Oncogenes: new targets in cancer treatment
ανά: Chowdhury, Waseka Shams
Έκδοση: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
ανά: Muntaha, Habibatul
Έκδοση: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
ανά: Haque, Mushfiqul
Έκδοση: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
ανά: Karim, Samia Binte
Έκδοση: (2024)